卵巢癌诊断和治疗市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

卵巢癌诊断和治疗市场按癌症类型(上皮卵巢肿瘤、卵巢生殖细胞肿瘤等)、模式(诊断和治疗)和地理细分。

市场快照

Ovarian Cancer Diagnostics and Therapeutics Market Size
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 9.5 %
Ovarian Cancer Diagnostics and Therapeutics Market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

卵巢癌是全球第五大女性癌症死亡原因,也是美国第十大女性癌症。55-64岁的女性卵巢癌的发病率很高。卵巢癌的主要症状包括腹胀、盆腔和腹痛、进食困难和泌尿系统症状。根据美国人口普查局的数据,60 岁以上的女性几乎占全球所有卵巢癌发病率的 57% 和所有与卵巢癌相关的死亡人数的 75%,诊断时的中位年龄为 63 岁,中位年龄为死亡70岁。因此,老年人口的增加正在推动卵巢癌诊断和治疗市场的增长。准确诊断卵巢癌至关重要,因为在大多数情况下,在诊断时,癌症已经开始扩散到淋巴结和骨盆外。Ovariancancerawareness.org 报告说,早期发现 1 期卵巢癌的 5 年生存率为 93%,并且大多数新发卵巢癌病例在 3 期或更晚时被诊断出来,几乎没有时间和准确诊断的空间.

报告范围

卵巢癌是一种始于卵巢的癌症。卵巢癌有几种类型,上皮性卵巢癌是最常见的卵巢癌类型。卵巢癌是由卵巢组织中不受控制的细胞生长引起的。这是一个日益受到关注的问题,也是全世界女性最常见的死亡原因之一。

By Cancer Type
Epithelial Ovarian Tumors
Ovarian Germ Cell Tumors
Others
By Modality
Diagnosis
Biopsy
Blood Tests
Ultrasound
PET
CT Scan
Other Diagnosis
Therapeutics
Chemotherapy
Radiation Therapy
Immunotherapy
Hormonal Therapy
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

CT扫描板块有望在预测期内呈现较好增长

计算机断层扫描 (CT) 是一种成像程序,它使用特殊的 X 射线设备来创建身体内部区域的详细图片或扫描。它也被称为计算机断层扫描和计算机轴向断层扫描 (CAT)。这些设备不能很好地显示小的卵巢肿瘤,但它们可以看到较大的肿瘤,并且可能能够看到肿瘤是否正在生长到附近的结构中。它还可以发现肿大的淋巴结、癌症扩散到肝脏或其他器官的迹象,或者卵巢肿瘤正在影响肾脏或膀胱的迹象。此外,随着卵巢癌负担的增加和技术进步,预计将在预测期内推动市场增长。

Ovarian Cancer Diagnostics and Therapeutics Market Share

预计美国在预测期内将保持最大的市场份额。

在北美地区,美国在卵巢癌诊断和治疗市场中占有最高份额,并为此做出了重大贡献。卵巢癌是美国第九大最常见的癌症,也是美国女性癌症死亡的第五大原因。据美国癌​​症协会估计,2020年,美国将新增约21,750例卵巢癌病例,13,940名女性将死于卵巢癌。此外,大多数全球顶级卵巢癌诊断公司的总部都设在美国,这往往是该地区的主要优势,预计将推动市场。

Ovarian Cancer Diagnostics and Therapeutics Market Analysis

竞争格局

卵巢癌诊断和治疗市场竞争激烈,由几个主要参与者组成。就市场份额而言,目前很少有主要参与者主导市场。市场上的主要参与者包括阿斯利康、勃林格殷格翰、百时美施贵宝公司、礼来公司、F. Hoffman-La Roche Ltd、葛兰素史克公司、强生公司、Amneal Pharmaceuticals 和 Siemens Healthineers AG 等。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Burden of Ovarian Cancer

      2. 4.2.2 Use of Combination Therapies for the Treatment of Ovarian Cancer

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Accurate Diagnosis of Ovarian Cancer

      2. 4.3.2 Lack of Awareness in Emerging and Low Income Economies

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Cancer Type

      1. 5.1.1 Epithelial Ovarian Tumors

      2. 5.1.2 Ovarian Germ Cell Tumors

      3. 5.1.3 Others

    2. 5.2 By Modality

      1. 5.2.1 Diagnosis

        1. 5.2.1.1 Biopsy

        2. 5.2.1.2 Blood Tests

        3. 5.2.1.3 Ultrasound

        4. 5.2.1.4 PET

        5. 5.2.1.5 CT Scan

        6. 5.2.1.6 Other Diagnosis

      2. 5.2.2 Therapeutics

        1. 5.2.2.1 Chemotherapy

        2. 5.2.2.2 Radiation Therapy

        3. 5.2.2.3 Immunotherapy

        4. 5.2.2.4 Hormonal Therapy

        5. 5.2.2.5 Others

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle-East and Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle-East and Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Amneal Pharmaceuticals LLC

      2. 6.1.2 Astrazeneca plc

      3. 6.1.3 Boehringer Ingelheim International GmbH

      4. 6.1.4 Bristol Myers Squibb Company

      5. 6.1.5 Eli Lilly and Company

      6. 6.1.6 F. Hoffman-La Roche Ltd

      7. 6.1.7 Glaxosmithkline Plc

      8. 6.1.8 Johnson and Johnson (Janssen Pharmaceuticals)

      9. 6.1.9 Pfizer Inc.

      10. 6.1.10 Siemens Healthineers AG

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Ovarian Cancer Diagnostics and Therapeutics Market market is studied from 2018 - 2026.

The Ovarian Cancer Diagnostics and Therapeutics Market is growing at a CAGR of 9.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Astrazeneca plc, F. Hoffmann-La Roche Ltd, Siemens Healthineers AG, Glaxosmithkline Plc, Johnson and Johnson (Janssen Pharmaceuticals) are the major companies operating in Ovarian Cancer Diagnostics and Therapeutics Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!